Synthesis and Exon-Skipping Properties of a 3′-Ursodeoxycholic Acid-Conjugated Oligonucleotide Targeting DMD Pre-mRNA: Pre-Synthetic versus Post-Synthetic Approach - Plateforme d’immortalisation MyoLine – CRM Access content directly
Journal Articles Molecules Year : 2021

Synthesis and Exon-Skipping Properties of a 3′-Ursodeoxycholic Acid-Conjugated Oligonucleotide Targeting DMD Pre-mRNA: Pre-Synthetic versus Post-Synthetic Approach

Abstract

Steric blocking antisense oligonucleotides (ASO) are promising tools for splice modulation such as exon-skipping, although their therapeutic effect may be compromised by insufficient delivery. To address this issue, we investigated the synthesis of a 20-mer 2′-OMe PS oligonucleotide conjugated at 3′-end with ursodeoxycholic acid (UDCA) involved in the targeting of human DMD exon 51, by exploiting both a pre-synthetic and a solution phase approach. The two approaches have been compared. Both strategies successfully provided the desired ASO 51 3′-UDC in good yield and purity. It should be pointed out that the pre-synthetic approach insured better yields and proved to be more cost-effective. The exon skipping efficiency of the conjugated oligonucleotide was evaluated in myogenic cell lines and compared to that of unconjugated one: a better performance was determined for ASO 51 3′-UDC with an average 9.5-fold increase with respect to ASO 51.
Fichier principal
Vignette du fichier
molecules-26-07662-v2.pdf (3.46 Mo) Télécharger le fichier
Origin : Publication funded by an institution

Dates and versions

hal-03510261 , version 1 (04-01-2022)

Identifiers

Cite

Elena Marchesi, Matteo Bovolenta, Lorenzo Preti, Massimo L Capobianco, Kamel Mamchaoui, et al.. Synthesis and Exon-Skipping Properties of a 3′-Ursodeoxycholic Acid-Conjugated Oligonucleotide Targeting DMD Pre-mRNA: Pre-Synthetic versus Post-Synthetic Approach. Molecules, 2021, 26 (24), pp.7662. ⟨10.3390/molecules26247662⟩. ⟨hal-03510261⟩
27 View
35 Download

Altmetric

Share

Gmail Facebook X LinkedIn More